Global Needle-Free Drug Delivery Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: May-2021 | Id: MACRC-61759 | Geographical Scope: Global | Publisher: HNY Research
The global Needle-Free Drug Delivery market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Endo Pharmaceuticals Antares Pharma Inovio Pharmaceuticals Valeritas PharmaJet 3M Akra Dermojet Consort Medical PenJet BD Med Immune By Types: Jet injectors Transdermal drug delivery systems By Applications: Insulin delivery Vaccination Pain management Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Needle-Free Drug Delivery Revenue 1.5 Market Analysis by Type 1.5.1 Global Needle-Free Drug Delivery Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Jet injectors 1.5.3 Transdermal drug delivery systems 1.6 Market by Application 1.6.1 Global Needle-Free Drug Delivery Market Share by Application: 2022-2027 1.6.2 Insulin delivery 1.6.3 Vaccination 1.6.4 Pain management 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Needle-Free Drug Delivery Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Needle-Free Drug Delivery Market Players Profiles 3.1 Endo Pharmaceuticals 3.1.1 Endo Pharmaceuticals Company Profile 3.1.2 Endo Pharmaceuticals Needle-Free Drug Delivery Product Specification 3.1.3 Endo Pharmaceuticals Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Antares Pharma 3.2.1 Antares Pharma Company Profile 3.2.2 Antares Pharma Needle-Free Drug Delivery Product Specification 3.2.3 Antares Pharma Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Inovio Pharmaceuticals 3.3.1 Inovio Pharmaceuticals Company Profile 3.3.2 Inovio Pharmaceuticals Needle-Free Drug Delivery Product Specification 3.3.3 Inovio Pharmaceuticals Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Valeritas 3.4.1 Valeritas Company Profile 3.4.2 Valeritas Needle-Free Drug Delivery Product Specification 3.4.3 Valeritas Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 PharmaJet 3.5.1 PharmaJet Company Profile 3.5.2 PharmaJet Needle-Free Drug Delivery Product Specification 3.5.3 PharmaJet Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 3M 3.6.1 3M Company Profile 3.6.2 3M Needle-Free Drug Delivery Product Specification 3.6.3 3M Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Akra Dermojet 3.7.1 Akra Dermojet Company Profile 3.7.2 Akra Dermojet Needle-Free Drug Delivery Product Specification 3.7.3 Akra Dermojet Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Consort Medical 3.8.1 Consort Medical Company Profile 3.8.2 Consort Medical Needle-Free Drug Delivery Product Specification 3.8.3 Consort Medical Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 PenJet 3.9.1 PenJet Company Profile 3.9.2 PenJet Needle-Free Drug Delivery Product Specification 3.9.3 PenJet Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 BD 3.10.1 BD Company Profile 3.10.2 BD Needle-Free Drug Delivery Product Specification 3.10.3 BD Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Med Immune 3.11.1 Med Immune Company Profile 3.11.2 Med Immune Needle-Free Drug Delivery Product Specification 3.11.3 Med Immune Needle-Free Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Needle-Free Drug Delivery Market Competition by Market Players 4.1 Global Needle-Free Drug Delivery Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Needle-Free Drug Delivery Revenue Market Share by Market Players (2016-2021) 4.3 Global Needle-Free Drug Delivery Average Price by Market Players (2016-2021) 5 Global Needle-Free Drug Delivery Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Needle-Free Drug Delivery Market Size (2016-2021) 5.1.2 Needle-Free Drug Delivery Key Players in North America (2016-2021) 5.1.3 North America Needle-Free Drug Delivery Market Size by Type (2016-2021) 5.1.4 North America Needle-Free Drug Delivery Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Needle-Free Drug Delivery Market Size (2016-2021) 5.2.2 Needle-Free Drug Delivery Key Players in East Asia (2016-2021) 5.2.3 East Asia Needle-Free Drug Delivery Market Size by Type (2016-2021) 5.2.4 East Asia Needle-Free Drug Delivery Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Needle-Free Drug Delivery Market Size (2016-2021) 5.3.2 Needle-Free Drug Delivery Key Players in Europe (2016-2021) 5.3.3 Europe Needle-Free Drug Delivery Market Size by Type (2016-2021) 5.3.4 Europe Needle-Free Drug Delivery Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Needle-Free Drug Delivery Market Size (2016-2021) 5.4.2 Needle-Free Drug Delivery Key Players in South Asia (2016-2021) 5.4.3 South Asia Needle-Free Drug Delivery Market Size by Type (2016-2021) 5.4.4 South Asia Needle-Free Drug Delivery Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Needle-Free Drug Delivery Market Size (2016-2021) 5.5.2 Needle-Free Drug Delivery Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Needle-Free Drug Delivery Market Size by Type (2016-2021) 5.5.4 Southeast Asia Needle-Free Drug Delivery Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Needle-Free Drug Delivery Market Size (2016-2021) 5.6.2 Needle-Free Drug Delivery Key Players in Middle East (2016-2021) 5.6.3 Middle East Needle-Free Drug Delivery Market Size by Type (2016-2021) 5.6.4 Middle East Needle-Free Drug Delivery Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Needle-Free Drug Delivery Market Size (2016-2021) 5.7.2 Needle-Free Drug Delivery Key Players in Africa (2016-2021) 5.7.3 Africa Needle-Free Drug Delivery Market Size by Type (2016-2021) 5.7.4 Africa Needle-Free Drug Delivery Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Needle-Free Drug Delivery Market Size (2016-2021) 5.8.2 Needle-Free Drug Delivery Key Players in Oceania (2016-2021) 5.8.3 Oceania Needle-Free Drug Delivery Market Size by Type (2016-2021) 5.8.4 Oceania Needle-Free Drug Delivery Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Needle-Free Drug Delivery Market Size (2016-2021) 5.9.2 Needle-Free Drug Delivery Key Players in South America (2016-2021) 5.9.3 South America Needle-Free Drug Delivery Market Size by Type (2016-2021) 5.9.4 South America Needle-Free Drug Delivery Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Needle-Free Drug Delivery Market Size (2016-2021) 5.10.2 Needle-Free Drug Delivery Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Needle-Free Drug Delivery Market Size by Type (2016-2021) 5.10.4 Rest of the World Needle-Free Drug Delivery Market Size by Application (2016-2021) 6 Global Needle-Free Drug Delivery Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Needle-Free Drug Delivery Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Needle-Free Drug Delivery Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Needle-Free Drug Delivery Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Needle-Free Drug Delivery Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Needle-Free Drug Delivery Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Needle-Free Drug Delivery Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Needle-Free Drug Delivery Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Needle-Free Drug Delivery Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Needle-Free Drug Delivery Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Needle-Free Drug Delivery Consumption by Countries 7 Global Needle-Free Drug Delivery Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Needle-Free Drug Delivery (2022-2027) 7.2 Global Forecasted Revenue of Needle-Free Drug Delivery (2022-2027) 7.3 Global Forecasted Price of Needle-Free Drug Delivery (2022-2027) 7.4 Global Forecasted Production of Needle-Free Drug Delivery by Region (2022-2027) 7.4.1 North America Needle-Free Drug Delivery Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Needle-Free Drug Delivery Production, Revenue Forecast (2022-2027) 7.4.3 Europe Needle-Free Drug Delivery Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Needle-Free Drug Delivery Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Needle-Free Drug Delivery Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Needle-Free Drug Delivery Production, Revenue Forecast (2022-2027) 7.4.7 Africa Needle-Free Drug Delivery Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Needle-Free Drug Delivery Production, Revenue Forecast (2022-2027) 7.4.9 South America Needle-Free Drug Delivery Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Needle-Free Drug Delivery Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Needle-Free Drug Delivery by Application (2022-2027) 8 Global Needle-Free Drug Delivery Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Needle-Free Drug Delivery by Country 8.2 East Asia Market Forecasted Consumption of Needle-Free Drug Delivery by Country 8.3 Europe Market Forecasted Consumption of Needle-Free Drug Delivery by Countriy 8.4 South Asia Forecasted Consumption of Needle-Free Drug Delivery by Country 8.5 Southeast Asia Forecasted Consumption of Needle-Free Drug Delivery by Country 8.6 Middle East Forecasted Consumption of Needle-Free Drug Delivery by Country 8.7 Africa Forecasted Consumption of Needle-Free Drug Delivery by Country 8.8 Oceania Forecasted Consumption of Needle-Free Drug Delivery by Country 8.9 South America Forecasted Consumption of Needle-Free Drug Delivery by Country 8.10 Rest of the world Forecasted Consumption of Needle-Free Drug Delivery by Country 9 Global Needle-Free Drug Delivery Sales by Type (2016-2027) 9.1 Global Needle-Free Drug Delivery Historic Market Size by Type (2016-2021) 9.2 Global Needle-Free Drug Delivery Forecasted Market Size by Type (2022-2027) 10 Global Needle-Free Drug Delivery Consumption by Application (2016-2027) 10.1 Global Needle-Free Drug Delivery Historic Market Size by Application (2016-2021) 10.2 Global Needle-Free Drug Delivery Forecasted Market Size by Application (2022-2027) 11 Global Needle-Free Drug Delivery Manufacturing Cost Analysis 11.1 Needle-Free Drug Delivery Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Needle-Free Drug Delivery 12 Global Needle-Free Drug Delivery Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Needle-Free Drug Delivery Distributors List 12.3 Needle-Free Drug Delivery Customers 12.4 Needle-Free Drug Delivery Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000